SciELO - Scientific Electronic Library Online

 
 issue62PET/CT applications in oncologyRadiopharmaceutical market. Cuban scenario author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Nucleus

On-line version ISSN 2075-5635

Abstract

OLIVA GONZALEZ, Juan P et al. Somatostatin receptor scintigraphy with http://img/revistas/nuc/n62/e01046217.jpg-DOTATATE PET/CT: initial experience in Cuba. Nucleus [online]. 2017, n.62, pp. 14-23. ISSN 2075-5635.

In 1870, Rudolf Heidenhain discovered neuroendocrine cells, which can lead to the development of the Neuroendocrine Tumors (NER), a rare form of cancer, most of which express somatostatin receptors. The basis of Receptor Scintigraphy as a metabolic-molecular image is based on the use of http://img/revistas/nuc/n62/e01046217.jpg-DOTA-peptides with specific binding to somatostatin receptors.The purpose of this publication is to present our first experiences in the study of different histological types of TNE by means of Somatostatin Receptor Scintigraphy (GRS) using http://img/revistas/nuc/n62/e01046217.jpg-DOTATATE performed at the PET / CT Center and Molecular Image of the Department of Nuclear Medicine of the National Institute of Oncology and Radiobiology (Inor)

Keywords : endocrine diseases; positron computed tomography; tomography; gallium 68; neoplasms.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License